| dc.description | CORE LEADERSHIP GROUP: Core Leadership Group: Steven Deeks1, Sharon Lewin17, Marein de Jong6, Rosanne Lamplough8 and Simon Collins4 Working Group 1 (Understanding HIV reservoirs) R. Brad Jones5, Zaza Ndhlovu18, Nicolas Chomont19, Zabrina Brumme20, Kai Deng21, Luke Jasenosky22, Richard Jefferys23 and Aurelio Orta-Resendiz24 Working Group 2 (HIV reservoir measurement) Linos Vandekerckhove14, Frank Mardarelli25, Monique Nijhuis26, Katharine Bar27, Bonnie Howell28,
Alex Schneider29, Gabriela Turk30,31 and Rose Nabatanzi32 Working Group 3 (Mechanisms of virus control) Olivier Lambotte7, Joel Blankson33, J. Victor Garcia34, Mirko Paiardini35, Jan van Lunzen36, Christina Antoniadi37 and Fernanda Heloise Côrtes38 Working Group 4 (Targeting the provirus) Nancie Archin2, Susana Valente39, Ole S. Søgaard40, Ricardo Sobhie Diaz41, Melannie Ott42, Richard (Rick) Dunham43, Siegfried Schwarze44, Santiago Perez Patrigeon45 and Josephine Nabukenya46 Working Group 5 (Targeting the immune system) Thumbi Ndung’u9,10,11, Marina Caskey47, Beatriz Mothe48, Fu Sheng Wang49, Sarah Fidler50, Devi SenGupta51, Stephan Dressler52 and Mitch Matoga53 Working Group 6 (Cell and gene therapy) Paula Cannon3, Hans-Peter Kiem54, Pablo Tebas27, Cissy Kityo55, Boro Dropulic56, Michael Louella57 and Kumitaa Theva Das58 Working Group 7 (Paediatric remission and cure) Caroline T. Tiemessen13, Deborah Persaud59, Ann Chahroudi60, Katherine Luzuriaga61, Thanyawee Puthanakit62, Jeffrey Safrit63 and Gaerolwe Masheto64 - Jeremy Sugarman12, Karine Dubé65, Jennifer Power66, Jessica Salzwedel67, Udom Likhitwonnawut68, Jeff Taylor69, Oguzhan Latif Nuh70, Krista Dong11 and Edward Nelson Kankaka71. 18UKZN, Durban, South Africa. 19Centre de Recherche du CHUM and Université de Montréal, Montreal, Canada. 20BC Centre for Excellence in HIV/AIDS, Faculty of Health Sciences, Simon Fraser University, Vancouver, Canada. 21Sun Yat-sen University, Guangzhou, China. 22ViiV Healthcare, Branford, CT, USA. 23Treatment Action Group, New York, NY, USA. 24Institut Pasteur, Université de Paris, Unité HIV, Inflammation et Persistance, Paris, France. 25National Cancer Institute, Center for Cancer Research, Bethesda, MD, USA. 26UMC Utrecht, Utrecht, the Netherlands. 27Perelmann School of Medicine, University of Pennsylvania, Philadelphia, PA, USA. 28Merck & Co., Inc., Department of Infectious Disease & Vaccines, Kenilworth, NJ, USA. 29European AIDS treatment group (EATG), Zurich, Switzerland. 301CONICET – Universidad de Buenos Aires. Instituto de Investigaciones, Biomédicas en Retrovirus y SIDA (INBIRS), Buenos Aires, Argentina. 31Facultad de Medicina, Departamento de Microbiología, Parasitología e Inmunología, Buenos Aires, Argentina. 32Makerere University, Makerere, Uganda. 33John Hopkins School of Medicine, Baltimore, MD, USA. 34ICATS, UNC School of Medicine, Chapel Hill, NC, USA. 35Emory University School of Medicine, Yerkes National Primate Research Center, Atlanta, GA, USA. 36ViiV Healthcare, London, UK. 37Chelsea and Westminster Hospital NHS Foundation Trust, London, UK. 38Laboratório de AIDS e Imunologia Molecular, Instituto Oswaldo Cruz, Rio de Janeiro, Brazil. 39Scripps Research Institute, Jupiter, FL, USA. 40Aarhus University Hospital, Aarhus, Denmark. 41Universidade Federal de Sao Paulo, Sao Paulo, Brazil. 42Gladstone Institute of Virology, University of California San Francisco, San Francisco, CA, USA. 43USAHIV Drug Discovery, ViiV Healthcare, Qura Therapeutics, and UNC HIV Cure Center, University of North Carolina at Chapel Hill, Research Triangle Park, NC, USA. 44EATG, Berlin, Germany. 45Queen’s University, Kingston, Ontario, Canada. 46MUJHU Care limited, Kampala, Uganda. 47The Rockefeller University, New York, NY, USA. 48IrsiCaixa AIDS Research Institute, HUGTIP, Badalona, Barcelona, Spain. 49Chinese Academy of Sciences, National Clinical Research Center for Infectious Diseases, Division of Treatment and Care, National Center for AIDS/STD Control and Prevention, Beijing, China. 50Imperial College London, Department of Infectious Disease, Faculty of Medicine, London, UK. 51Gilead Sciences, Foster City, CA, USA. 52European AIDS Treatment Group (EATG), Brussels, Belgium. 53University of North Carolina Project Malawi, Lilongwe, Malawi. 54Fred Hutchinson Cancer Research Center, Seattle, WA, USA. 55Joint Clinical Research Centre, Kampala, Uganda. 56Caring Cross, Gaithersburg, MD, USA. 57University of Washington, Seattle, WA, USA. 58Advanced Medical and Dental Institute, Universiti Sains Malaysia, Pulau Pinang, Malaysia. 59Johns Hopkins University School of Medicine, Baltimore, MD, USA. 60Emory University School of Medicine and Children’s Healthcare of Atlanta, Atlanta, GA, USA. 61University of Massachusetts, Worcester, MA, USA. 62Chulalongkorn University, Bangkok, Thailand. 63ImmunityBio, Inc, Culver City, CA, USA. 64Botswana Harvard AIDS Institute Partnership, Gaborone, Botswana. 65UNC Gillings School of Global Public Health, Chapel Hill, NC, USA. 66La Trobe University, Melbourne, Australia. 67AVAC, New York, NY, USA. 68VARG, Chiang Mai, Thailand. 69UCSD AntiViral Research Center, Delaney AIDS Research Enterprise/UCSF, Palm Springs, CA, USA. 70Social Policy, Gender Identity, and Sexual Orientation Studies Association (SPoD), University of Lucerne MSc Health Sciences, Istanbul, Turkey. 71Rakai Health Sciences Program, Rakai, Uganda. | |
